mizolastine has been researched along with Nasal Polyps in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Soussen, P; Bousquet, J; Carayol, N; Crampette, L; Lebel, B; Mainprice, B; Verrecchia, M | 1 |
| Cagnoni, F; Canonica, GW; Dellacasa, P; Oddera, S | 1 |
2 other study(ies) available for mizolastine and Nasal Polyps
| Article | Year |
|---|---|
Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastine.
Topics: Adult; Antibodies, Anti-Idiotypic; Benzimidazoles; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Epithelial Cells; Female; Histamine H1 Antagonists; Humans; Inflammation Mediators; Leukocytes; Male; Mast Cells; Middle Aged; Nasal Polyps; Neoplastic Cells, Circulating; Treatment Outcome | 2002 |
Effects of mizolastine in vitro on human immunocompetent and airway cells: evidence for safety and additional property.
Topics: Adolescent; Adult; Aged; Benzimidazoles; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flow Cytometry; Histamine H1 Antagonists; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Nasal Mucosa; Nasal Polyps; T-Lymphocytes | 2000 |